Molecular Cardiology in Translation: Gene, Cell and Chemical-based Experimental Therapeutics for the Failing Heart

Overview

Journal J Cardiovasc Transl Res

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2009 Dec 4

PMID 19956787

Citations 2

Authors

Immanuel Turner

Fikru Belema-Bedada

Joshua Martindale

DeWayne Townsend

Wang Wang

Nathan Palpant

So-Chiro Yasuda

Matthew Barnabei

Ekaterina Fomicheva

Joseph M Metzger

Affiliations

Soon will be listed here.

Abstract

Acquired and inherited diseases of the heart represent a major health care issue in this country and throughout the World. Clinical medicine has made important advancements in the past quarter century to enable several effective treatment regimes for cardiac patients. Nevertheless, it is apparent that even with the best care, current treatment strategies and therapeutics are inadequate for treating heart disease, leaving it arguably the most pressing health issue today. In this context it is important to seek new approaches to redress the functional deficits in failing myocardium. This review focuses on several recent gene, cell and chemical-based experimental therapeutics currently being developed in the laboratory for potential translation to patient care. For example, new advances in bio-sensing inducible gene expression systems offer the potential for designer cardio-protective proteins to be expressed only during hypoxia/ischemia in the heart. Stem cells continue to offer the promise of cardiac repair, and some recent advances are discussed here. In addition, discovery and applications of synthetic polymers are presented as a chemical-based strategy for acute and chronic treatment of diseased and failing cardiac tissue. Collectively, these approaches serve as the front lines in basic biomedical research, with an eye toward translation of these findings to clinically meaningful applications in cardiac disease.

Citing Articles

Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Warren S, Briggs L, Zeng H, Chuang J, Chang E, Terada R Circulation. 2012; 126(22):2575-88.

PMID: 23095280 PMC: 3510779. DOI: 10.1161/CIRCULATIONAHA.112.116202.

Aesthetic cardiology: adipose-derived stem cells for myocardial repair.

Palpant N, Metzger J Curr Stem Cell Res Ther. 2009; 5(2):145-52.

PMID: 19941452 PMC: 2896012. DOI: 10.2174/157488810791268654.

References

Day S, Westfall M, Fomicheva E, Hoyer K, Yasuda S, La Cross N . Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med. 2006; 12(2):181-9. DOI: 10.1038/nm1346. View

Ohh M, Park C, Ivan M, Hoffman M, Kim T, Huang L . Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol. 2000; 2(7):423-7. DOI: 10.1038/35017054. View

Clarke M, McNeil P . Syringe loading introduces macromolecules into living mammalian cell cytosol. J Cell Sci. 1992; 102 ( Pt 3):533-41. DOI: 10.1242/jcs.102.3.533. View

Ricciardi L, Bucx J, Ter Keurs H . Effects of acidosis on force-sarcomere length and force-velocity relations of rat cardiac muscle. Cardiovasc Res. 1986; 20(2):117-23. DOI: 10.1093/cvr/20.2.117. View

Thom T, Haase N, Rosamond W, Howard V, Rumsfeld J, Manolio T . Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113(6):e85-151. DOI: 10.1161/CIRCULATIONAHA.105.171600. View

Tang Y, Qian K, Kagiyama S, Phillips M . Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases. Methods. 2002; 28(2):259-66. DOI: 10.1016/s1046-2023(02)00231-1. View

Yasuda S, Townsend D, Michele D, Favre E, Day S, Metzger J . Dystrophic heart failure blocked by membrane sealant poloxamer. Nature. 2005; 436(7053):1025-9. DOI: 10.1038/nature03844. View

Parsons B, Szczesna D, Zhao J, Van Slooten G, Kerrick W, Putkey J . The effect of pH on the Ca2+ affinity of the Ca2+ regulatory sites of skeletal and cardiac troponin C in skinned muscle fibres. J Muscle Res Cell Motil. 1997; 18(5):599-609. DOI: 10.1023/a:1018623604365. View

Dargis R, Pearlstone J, Barrette-Ng I, Edwards H, Smillie L . Single mutation (A162H) in human cardiac troponin I corrects acid pH sensitivity of Ca2+-regulated actomyosin S1 ATPase. J Biol Chem. 2002; 277(38):34662-5. DOI: 10.1074/jbc.C200419200. View

10.

Takeda S, Yamashita A, Maeda K, Maeda Y . Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature. 2003; 424(6944):35-41. DOI: 10.1038/nature01780. View

11.

Binley K, Kan O, White J, Naylor S . Exploiting the hypoxia response. Curr Opin Mol Ther. 2004; 5(6):650-6. View

12.

Couzin J, Vogel G . Cell therapy. Renovating the heart. Science. 2004; 304(5668):192-4. DOI: 10.1126/science.304.5668.192. View

13.

Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

14.

Keith B, Simon M . Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007; 129(3):465-72. PMC: 3150586. DOI: 10.1016/j.cell.2007.04.019. View

15.

Ervasti J, Campbell K . Membrane organization of the dystrophin-glycoprotein complex. Cell. 1991; 66(6):1121-31. DOI: 10.1016/0092-8674(91)90035-w. View

16.

Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S, Li B . Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410(6829):701-5. DOI: 10.1038/35070587. View

17.

Boast K, Binley K, Iqball S, Price T, Spearman H, Kingsman S . Characterization of physiologically regulated vectors for the treatment of ischemic disease. Hum Gene Ther. 1999; 10(13):2197-208. DOI: 10.1089/10430349950017185. View

18.

Most P, Pleger S, Volkers M, Heidt B, Boerries M, Weichenhan D . Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest. 2004; 114(11):1550-63. PMC: 529280. DOI: 10.1172/JCI21454. View

19.

Lee R, RIVER L, Pan F, Ji L, Wollmann R . Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci U S A. 1992; 89(10):4524-8. PMC: 49115. DOI: 10.1073/pnas.89.10.4524. View

20.

Day S, Westfall M, Metzger J . Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function. J Mol Med (Berl). 2007; 85(9):911-21. DOI: 10.1007/s00109-007-0181-6. View